Research Topic: critical care

Diagnostic Approaches to Invasive Candidiasis: Challenges and New Perspectives

mycolabadmin

Invasive candidiasis is a serious fungal infection affecting critically ill patients in hospitals. Current testing methods like blood cultures are slow and sometimes miss the infection. Researchers are developing faster diagnostic tests using DNA detection and biomarkers that can identify infections within hours instead of days, allowing doctors to start treatment sooner and save more lives.

Read More »

The Prognostic Value of (1→3)-β-D-Glucan in COVID-19 Patients with and Without Secondary Fungal Disease

mycolabadmin

During COVID-19 infection, a fungal marker called beta-D-glucan (BDG) in the blood can predict patient survival even without a diagnosed fungal infection. Researchers found that COVID-19 patients with high BDG levels had a 91% death rate if not treated with antifungal drugs, but this dropped to 50% when antifungal therapy was given. The high BDG levels trigger a strong inflammatory response in the body that worsens disease severity, making BDG a valuable warning sign for doctors treating critically ill COVID-19 patients.

Read More »

Acute liver failure caused by Amanita verna: a case series and review of the literature

mycolabadmin

This case study examines three patients who became severely ill after eating poisonous Amanita verna mushrooms in China. One patient successfully received a liver transplant and recovered, while the other two died from brain bleeding complications. The study highlights that liver transplantation can be life-saving for mushroom poisoning victims with severe liver failure, though doctors need better guidelines to decide when transplantation is the right choice.

Read More »

Therapeutic Plasma Exchange in Acute Liver Failure: A Real-World Study in Mexico

mycolabadmin

Acute liver failure is a serious medical emergency where the liver suddenly stops working properly. This study found that a treatment called therapeutic plasma exchange (TPE), which filters the blood to remove harmful substances, significantly improved survival rates in liver failure patients treated in a Mexican hospital. Patients receiving TPE had a 92% survival rate at 30 days compared to only 50% in those receiving standard treatment alone, even though the TPE group had more severe cases at the start.

Read More »
Scroll to Top